S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Top Wellness Nasdaq Stock for 2023 (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Top Wellness Nasdaq Stock for 2023 (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Top Wellness Nasdaq Stock for 2023 (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Top Wellness Nasdaq Stock for 2023 (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Top Wellness Nasdaq Stock for 2023 (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Top Wellness Nasdaq Stock for 2023 (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Top Wellness Nasdaq Stock for 2023 (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Top Wellness Nasdaq Stock for 2023 (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Top Wellness Nasdaq Stock for 2023 (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
3 Top-Rated, Oversold Industry Giants
Top Wellness Nasdaq Stock for 2023 (Ad)
PayPal Keeps Getting Cheaper; Should You Load Up?
What's Really Behind The FTC's Lawsuit Targeting of Amazon?
Top Wellness Nasdaq Stock for 2023 (Ad)
Delta Hopes to Soar Again with Customer Loyalty Tweaks
Is the Grinch Stealing This Year's Holiday Season Jobs?
Top Wellness Nasdaq Stock for 2023 (Ad)
The Next Stage Of Google’s Rally Just Started
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023
NASDAQ:ORIC

ORIC Pharmaceuticals (ORIC) SEC Filings & 10K Form

$6.05
-0.08 (-1.31%)
(As of 09/29/2023 ET)
Compare
Today's Range
$5.88
$6.29
50-Day Range
$6.05
$9.28
52-Week Range
$2.36
$9.79
Volume
756,624 shs
Average Volume
308,562 shs
Market Capitalization
$329.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.00

Recent ORIC Pharmaceuticals SEC Filings

DateFilerForm TypeView
07/11/2023
8:28 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/07/2023
3:15 PM
Nextech Crossover I GP S.a r.l. (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G
07/05/2023
2:27 PM
ORIC Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
06/28/2023
6:18 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
5:05 AM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/26/2023
5:25 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2023
3:21 PM
ORIC Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/16/2023
3:21 PM
ORIC Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/16/2023
3:11 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/17/2023
3:22 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4/A
02/13/2023
9:15 AM
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/10/2023
12:56 PM
EcoR1 Capital, LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/09/2023
11:01 AM
ORIC Pharmaceuticals (Subject)
Form SC 13G/A
02/06/2023
8:50 AM
ORIC Pharmaceuticals (Subject)
VICTORY CAPITAL MANAGEMENT INC (Filed by)
Form SC 13G/A
02/02/2023
3:09 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2023
3:11 PM
ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2023
3:13 PM
Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/09/2023
7:12 AM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2022
3:41 PM
ORIC Pharmaceuticals (Subject)
PFIZER INC (Filed by)
Form SC 13G
12/29/2022
3:30 PM
ORIC Pharmaceuticals (Issuer)
PFIZER INC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/27/2022
3:36 PM
ORBIMED ADVISORS LLC (Filed by)
ORIC Pharmaceuticals (Subject)
Form SC 13D/A
12/21/2022
4:23 PM
ORIC Pharmaceuticals (Filer)
Form 424B5
12/21/2022
4:25 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2022
7:51 PM
Multani Pratik S (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2022
7:47 PM
Chacko Jacob (Reporting)
ORIC Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2022
7:49 PM
ORIC Pharmaceuticals (Issuer)
Piscitelli Dominic (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2022
3:21 PM
ORIC Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2022
3:10 PM
ORIC Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ORIC) was last updated on 9/30/2023 by MarketBeat.com Staff

My Account -